Wilson RS, Barnes LL, de Leon CFM, Aggarwal NT, Schneider JS, Bach J, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364–70.

Article  PubMed  Google Scholar 

Yin J, John A, Cadar D. Bidirectional Associations of Depressive Symptoms and Cognitive Function Over Time. JAMA Netw Open. 2024;7: e2416305.

Article  PubMed  PubMed Central  Google Scholar 

Rodríguez MR, Nuevo R, Chatterji S, Ayuso-Mateos JL. Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry. 2012;12:181.

Article  PubMed  PubMed Central  Google Scholar 

Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, et al. Depressive Symptoms and Biomarkers of Alzheimer’s Disease in Cognitively Normal Older Adults. J Alzheimers Dis. 2015;46:63–73.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jeuring HW, Huisman M, Comijs HC, Stek ML, Beekman ATF. The long-term outcome of subthreshold depression in later life. Psychol Med. 2016;46:2855–65.

Article  PubMed  CAS  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396:413–46.

Article  Google Scholar 

Belvederi Murri M, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, et al. HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology. 2014;41:46–62.

Article  PubMed  CAS  Google Scholar 

Henjum K, Watne LO, Godang K, Halaas NB, Eldholm RS, Blennow K, et al. Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease. Transl Psychiatry. 2022;12:1–9.

Article  Google Scholar 

Fitzgerald PJ. Is elevated norepinephrine an etiological factor in some cases of Alzheimer’s disease? Curr Alzheimer Res. 2010;7:506–16.

Article  PubMed  CAS  Google Scholar 

Godoy LD, Rossignoli MT, Delfino-Pereira P, Garcia-Cairasco N, de Lima Umeoka EH. A Comprehensive Overview on Stress Neurobiology: Basic Concepts and Clinical Implications. Frontiers in Behavioral Neuroscience. 2018 [cited 2022 Apr 6];12. Available from: https://www.frontiersin.org/article/10.3389/fnbeh.2018.00127.

Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis. Biol Psychiat. 2010;67:1067–74.

Article  PubMed  CAS  Google Scholar 

Brown L, Karmakar C, Gray R, Jindal R, Lim T, Bryant C. Heart rate variability alterations in late life depression: A meta-analysis. J Affect Disord. 2018;235:456–66.

Article  PubMed  Google Scholar 

Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 2005;67(Suppl 1):S29-33.

Article  PubMed  Google Scholar 

Peacock BN, Scheiderer DJ, Kellermann GH. Biomolecular aspects of depression: A retrospective analysis. Compr Psychiatry. 2017;73:168–80.

Article  PubMed  Google Scholar 

Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry. 1994;51:411–22.

Article  PubMed  CAS  Google Scholar 

Lechin F, van der Dijs B, Orozco B, Lechin ME, Báez S, Lechin AE, et al. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol Psychiat. 1995;38:166–73.

Article  PubMed  CAS  Google Scholar 

Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J. CSF and Urinary Biogenic Amines and Metabolites in Depression and Mania: A Controlled. Univariate Analysis Archives of General Psychiatry. 1983;40:999–1010.

Article  PubMed  CAS  Google Scholar 

Grossman F, Potter WZ. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Psychiatry Res. 1999;87:21–7.

Raskind MA, Peskind ER, Halter JB, Jimerson DC. Norepinephrine and MHPG levels in CSF and plasma in Alzheimer’s disease. Arch Gen Psychiatry. 1984;41:343–6.

Article  PubMed  CAS  Google Scholar 

Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Effects of Alzheimer’s disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry. 1997;154:25–30.

Article  PubMed  CAS  Google Scholar 

Stefani A, Olivola E, Liguori C, Hainsworth AH, Saviozzi V, Angileri G, et al. Catecholamine-Based Treatment in AD Patients: Expectations and Delusions. Front Aging Neurosci. 2015;7:67.

Article  PubMed  PubMed Central  Google Scholar 

Peskind ER, Elrod R, Dobie DJ, Pascualy M, Petrie E, Jensen C, et al. Cerebrospinal fluid epinephrine in Alzheimer’s disease and normal aging. Neuropsychopharmacology. 1998;19:465–71.

Article  PubMed  CAS  Google Scholar 

Pan X, Kaminga AC, Jia P, Wen SW, Acheampong K, Liu A. Catecholamines in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Front Aging Neurosci. 2020;12:184.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Umegaki H, Ikari H, Nakahata H, Yoshimura J, Endo H, Yamamoto T, et al. Low plasma epinephrine in elderly female subjects of dementia of Alzheimer type. Brain Res. 2000;858:67–70.

Article  PubMed  CAS  Google Scholar 

Bemelmans KJ, Noort A, de Rijk R, Middelkoop HAM, van Kempen GMJ, Goekoop JG. Plasma cortisol and norepinephrine in Alzheimer’s disease: opposite relations with recall performance and stage of progression. Acta Neuropsychiatr. 2007;19:231–7.

Article  PubMed  Google Scholar 

Kurup RK, Kurup PA. Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer’s disease. Int J Neurosci. 2003;113:361–81.

Article  PubMed  Google Scholar 

van Hooren RWE, Verhey FRJ, Ramakers IHGB, Jansen WJ, Jacobs HIL. Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer’s disease pathology. Neurobiol Aging. 2021;102:17–22.

Article  PubMed  Google Scholar 

Ouanes S, Popp J. High Cortisol and the Risk of Dementia and Alzheimer’s Disease: A Review of the Literature. Front Aging Neurosci. 2019 [cited 2019 Apr 24];11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405479/.

Qin D, Rizak J, Feng X, Yang S, Lü L, Pan L, et al. Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour. Sci Rep. 2016;6:30187.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Geerlings MI, Gerritsen L. Late-Life Depression, Hippocampal Volumes, and Hypothalamic-Pituitary-Adrenal Axis Regulation: A Systematic Review and Meta-analysis. Biol Psychiat. 2017;82:339–50.

Article  PubMed  CAS  Google Scholar 

Ryff CD, Love GD, Urry HL, Muller D, Rosenkranz MA, Friedman EM, et al. Psychological Well-Being and Ill-Being: Do They Have Distinct or Mirrored Biological Correlates? PPS. 2006;75:85–95.

Google Scholar 

Bremmer MA, Deeg DJH, Beekman ATF, Penninx BWJH, Lips P, Hoogendijk WJG. Major Depression in Late Life Is Associated with Both Hypo- and Hypercortisolemia. Biol Psychiat. 2007;62:479–86.

Article  PubMed  CAS  Google Scholar 

Touron E, Moulinet I, Kuhn E, Sherif S, Ourry V, Landeau B, et al. Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network. Mol Psychiatry. 2022;27:5086–95.

Poisnel G, Arenaza-Urquijo E, Collette F, Klimecki OM, Marchant NL, Wirth M, et al. The Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults. Alzheimers Dement (N Y). 2018;4:714–23.

Article  PubMed